The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2007-10-04
- Last Posted Date
- 2017-09-26
- Target Recruit Count
- 45
- Registration Number
- NCT00539253
- Locations
- 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
- Conditions
- Gastrointestinal Cancer
- Interventions
- Procedure: Blood drawing
- First Posted Date
- 2007-10-04
- Last Posted Date
- 2009-08-14
- Target Recruit Count
- 60
- Registration Number
- NCT00539318
- Locations
- 🇸🇬
Johns Hopkins Singapore International Medical Centre, Singapore, Singapore
Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers
- Conditions
- Acute Myeloid LeukemiaLeukemia, Bilineage, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myeloid, Chronic
- Interventions
- Biological: Ex vivo expansion of cord blood
- First Posted Date
- 2007-10-04
- Last Posted Date
- 2020-02-18
- Target Recruit Count
- 3
- Registration Number
- NCT00539656
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
- Conditions
- Head and Neck CancerPrecancerous Condition
- Interventions
- Biological: cetuximab
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2020-03-12
- Target Recruit Count
- 35
- Registration Number
- NCT00524017
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Sirolimus in Treating Patients With Advanced Pancreatic Cancer
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2016-10-19
- Target Recruit Count
- 47
- Registration Number
- NCT00499486
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2019-01-18
- Target Recruit Count
- 19
- Registration Number
- NCT00499733
- Locations
- 🇺🇸
Brady Urological Institute at Johns Hopkins Hospital, Baltimore, Maryland, United States
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
- Conditions
- Esophageal Cancer
- Interventions
- Procedure: adjuvant therapyRadiation: radiation therapy
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2018-12-06
- Target Recruit Count
- 19
- Registration Number
- NCT00493025
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
High-Dose Cyclophosphamide for Steroid Refractory GVHD
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2018-09-14
- Target Recruit Count
- 12
- Registration Number
- NCT00492921
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders
- Conditions
- Sickle Cell Disease
- Interventions
- Procedure: Allogeneic bone marrow transplantRadiation: Total body irradiation - 200Biological: Anti-thymocyte globulinRadiation: Total body irradiation - 400
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2019-04-17
- Target Recruit Count
- 43
- Registration Number
- NCT00489281
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2019-07-10
- Target Recruit Count
- 92
- Registration Number
- NCT00486603
- Locations
- 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States